ANDS - Sector: Healthcare---Industry: Biotechnology & Drugs

[setravis]

Anadys Pharmaceuticals(ANDS), Kentucky First Federal and Zion Oil and Gas among 52-week highs.

                                                             Price
ANDS ANADYS PHARMACEUTICALS INC   7.06      
KFFB KENTUCKY FIRST FED BANCORP     11.40    
ZN ZION OIL & GAS INC                          11.05    
TSYS TELECOMMUNICATION SYS INC        9.56
MTXX MATRIXX INITIATIVES INC              19.10  
SIGA SIGA TECHNOLOGIES INC                 5.76    
GGA GSC ACQUISITION COMPANY              9.63

52wk Range: 1.41 - 6.30
Volume: 522,468
Avg Vol (3m): 310,927

Technicals
Record Price High
Percentage Gainer

Last Price Quote is:
24.10%above 13-day MA
67.83%above 50-day MA
RS Rating: 98  

Fundamentals
Earnings Expected on Feb 18

Key Data:
Market Cap (M): $176.40  
P/E Ratio: NA  
PEG Ratio: N/A  
Next Earnings: 04/22/2009
Last Analyst Rating: Buy

[setravis]

Profile: 



Anadys Pharmaceuticals Inc.
3115 Merryfield Row
San Diego, CA 92121
United States - Map
Phone: 858-530-3600
Web Site: http://www.anadyspharma.com

DETAILS   
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 50


BUSINESS SUMMARY   
Anadys Pharmaceuticals, Inc., a biopharmaceutical company, engages in developing medicines in the areas of hepatitis C and oncology. It develops ANA598, a small-molecule non-nucleoside inhibitor of the NS5B polymerase for the treatment of hepatitis C; and ANA773, an oral toll-like receptor 7 agonist prodrug for cancer. The company was founded in 1992. It was formerly known as ScripTech Pharmaceuticals, Inc. and changed its name to Scriptgen Pharmaceuticals, Inc. in 1994. Later, the company changed its name to Anadys Pharmaceuticals, Inc. in 2000. Anadys Pharmaceuticals is headquartered in San Diego, California.